⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 27, 2024Pediatric PulmonologyOpen Access

Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study

Yoni E. van Dijk Milou A. Brandsen Simone Hashimoto Niels W. Rutjes Korneliusz Golebski Frederique Vermeulen Suzanne W. J. Terheggen‐Lagro Bart E. van Ewijk Anke H. Maitland‐van der Zee Susanne J. H. Vijverberg

View Full Paper

Ask AI

Bookmark

Share

Abstract

Despite the availability of biologics for severe pediatric asthma, real-life studies reporting on drivers behind initiating biologics and their alignment with the Global Initiative for Asthma (GINA) recommendations are lacking.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dijk et al. (2024) studied this question.

synapsesocial.com/papers/68e63003b6db6435875c1f59 https://doi.org/10.1002/ppul.27145

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Real-world effectiveness of asthma biologics by age of initiation and early-childhood risk factorsOriginal Research · 2026 · 2 citations
2C25-20 Real-World Effectiveness of Asthma Biologics by Age of Initiation and Early-Childhood Risk FactorsOriginal Research · 2026
3Biologic Therapies for Severe Pediatric Asthma: Current Evidence, Clinical Indications, and Future DirectionsHuman Clinical Trial · 2026 · 1 citations
4The use of biologic therapies in pediatric severe asthma2025 · 5 citations
5Rate and predictors of biologic initiation in patients with severe asthma: a retrospective cohort studyRetrospective Study · 2026